Payer+Provider's Health System Review
December 1, 2020
With Pfizer, Moderna, and Astrozeneca Covid-19 vaccine trials showing promise, the U.S. needs a way to inoculate enough of its population to achieve herd immunity. Paying Americans $1,000 to get the vaccine could be a simple, yet effective proposal.